Bobby Ramakant - CNS’ Post

From May 30 –31, the Data.FI project supported two virtual workshops in #Panama. The workshops were organized by the Ministry of Health’s National STI/HIV Program for partners from the health regions that were implementing HIV situation rooms with the goal of exchanging experiences and good practices related to the use of HIV data. The two workshops brought together #healthcareworkers and other regional staff from Bocas del Toro, Chiriquí, and the Ngäbe Buglé Comarca (for the first workshop), and from Guna Yala, the Panama City Metropolitan Area, and San Miguelito (for the second workshop). During the data review portion of the workshops, the team observed remarkable recent progress. In Chiriquí, recent data cleaning efforts resulted in a 33% drop (from 36% to 3%) among people who knew their HIV status but did not receive antiretroviral therapy. And from January to April 2024, the Ngäbe Buglé Comarca health region witnessed an increase in viral load testing coverage from 75% to 85%. These workshops matter because they facilitate collaboration between local implementing partners to spread data-driven practices that can be replicated to yield positive health outcomes in other regions. Furthermore, in exchanging local solutions in Panama, Data.FI is also strengthening the learning capacity across regions. #USAID #PEPFAR #CentralAmerica #HIV #DataUse #ExchangeIdeas #Workshops #LocalSolutions #CapacityStrengthening

MSH at #AIDS2024: We appreciate the work of #journalists and believe they play a critical role in #publichealth. So we always make time to engage them. Here are MSH President and CEO, Marian Wentworth, and MSH Technical Director of Infectious Diseases and #HIV and #AIDS Lead Sarah Konopka at the International AIDS Conference 2024 with Anna Miti of #Zimbabwe's Broadcasting Corporation and Lorraine Mwanza of #Zambia's Media Science Cafe MESICA. Journalists ask: What role do international NGOs like MSH play in the fight against HIV? What are some of the behind-the-scenes efforts that make services possible? How does MSH help countries shore up their #supplychains and #pharmaceuticalsystems to ensure everyone, everywhere has access to the medicines and supplies they need to prevent and treat HIV? What are some of the biggest challenges we see, and opportunities for progress? As donor support dwindles, what role can NGOs like MSH play in helping countries adapt and transform their health systems so no one is left behind? Journalists translate our language—which can sometimes be too technical, sometimes too detailed—into something more accessible to the people who need to know—whether a community member, a stakeholder organization, or even a policy maker. What do you want to know? (L-R: anna miti, lorraine mwanza, Marian Wentworth, and Sarah Konopka) Internews Ida Jooste Ida Jooste

#WorldAIDSDay: Let's End the Epidemic Together Today, on World AIDS Day, we stand united in the fight against HIV/AIDS. It's a day to remember those we've lost, celebrate the progress we've made, and recommit ourselves to ending this epidemic. #HIVAIDS remains a global health crisis with 1.3 million new HIV infections 600,000 #AIDS -related deaths and 39.9 million people living with #HIV globally, says the latest Statista report. At eTeam Healthcare Talent Solutions, we're committed to supporting #healthcare professionals who are on the frontlines of this battle. By connecting top talent with leading #healthcare organizations, we contribute to a healthier future. Here's how you can make a difference: #GetTested: Knowing your status is the first step towards prevention and treatment. Educate Yourself: Learn about HIV/AIDS, transmission, and prevention methods. #BreaktheStigma: Challenge stereotypes and promote understanding and compassion. Support Organizations: Donate to or volunteer with organizations working to end the epidemic. Together, we can create a future where HIV/AIDS is no longer a threat. Let's empower ourselves, our communities, and the world. #EndHIV #HIVPrevention #AIDSawareness #HealthcareTalent #GlobalHealth

An estimated 39 million people worldwide are living with HIV/AIDS, with 2.3 million in India alone. Until there's a vaccine, the significance of early diagnosis and immediate care for HIV patients can't be overstated. Today is HIV Vaccine Awareness Day (#HVAD) and we're highlighting our work in India with AHF India Cares to screen patients and connect them with care, so they can receive the necessary treatment as quickly as possible: https://lnkd.in/g7HbW4KT Learn more about our global health work: https://lnkd.in/ghUpS-9U #HIV | #AIDS | #Vaccine | #India | AIDS Healthcare Foundation | #GlobalHealth | #Development | #ImpactAtScale

Today is World HIV Vaccine Awareness Day! While the scientific community continues its incredible work towards a vaccine, early testing remains the key to controlling the spread of HIV and ensuring access to proper care. At Palladium: Make It Possible , we're proud to be a part of the Community Based HIV Testing and Linkage project led by AHF India Cares Foundation This initiative operates across 9 states and 22 districts in India, with the ambitious goal of achieving 100% linkage to care for people living with HIV/AIDS. Our dedicated team set up screening centres and provide compassionate guidance and support to those who test positive, helping them understand that HIV is not the end; with early diagnosis and proper care, they can lead healthy, fulfilling lives. It's crucial to remove the stigma and support those affected, guiding them towards a fearless future. In 2023, the project screened a total of 251,000 people and connected 90% of patients to antiretroviral therapy. This year, the program has already screened 66,187 people for HIV and found 994 people HIV positive with 84% linked to antiretroviral therapy (ART). The fight is still on as we aim to achieve 100% linkage to care for people living with HIV/AIDS. Read a powerful story of someone who received the support from this program and leading a life of dignity today. #WorldHIVVaccineAwarenessDay #HIVTesting #CBHTL #AHFIndiaCares #Palladium #India #EndHIVStigma Ankit Srivastava , Ranjit Nayak PRINCE2® , Nidhi Tikku PRINCE2® , Pragya Mishra

🌍 𝗗𝗲𝗰𝗲𝗺𝗯𝗲𝗿 𝟭𝘀𝘁 - 𝗪𝗼𝗿𝗹𝗱 𝗔𝗜𝗗𝗦 𝗗𝗮𝘆 ❤️ We join the global community to raise awareness about HIV/AIDS and to remind everyone that together we can make a difference. 🎗️ 𝗣𝗿𝗲𝘃𝗲𝗻𝘁𝗶𝗼𝗻 𝗶𝘀 𝗸𝗲𝘆 HIV is no longer a death sentence, but early diagnosis is crucial to access timely treatment and live a full, healthy life. 🔬 𝗣𝗥𝗜𝗠𝗔 𝗟𝗮𝗯 𝗥𝗮𝗽𝗶𝗱 𝗧𝗲𝘀𝘁: 𝗪𝗵𝘆 𝘄𝗮𝗶𝘁? With HIV 1/2 Self-Test, you can get results in just 10 minutes, conveniently and discreetly. Taking the test is an act of responsibility towards yourself and others. 💡 𝗗𝗶𝗱 𝘆𝗼𝘂 𝗸𝗻𝗼𝘄…? - In 2023, millions of people are living with HIV without knowing it. - Getting tested is the first step to protecting yourself and your loved ones. 👉 𝗧𝗼𝗱𝗮𝘆 𝗶𝘀 𝘁𝗵𝗲 𝗽𝗲𝗿𝗳𝗲𝗰𝘁 𝗱𝗮𝘆 𝘁𝗼 𝘁𝗮𝗸𝗲 𝗮𝗰𝘁𝗶𝗼𝗻. Let’s talk openly, get informed, and most importantly, take the test. 𝗬𝗼𝘂 𝗮𝗿𝗲 𝘆𝗼𝘂𝗿 𝗳𝗶𝗿𝘀𝘁 𝗹𝗶𝗻𝗲 𝗼𝗳 𝗱𝗲𝗳𝗲𝗻𝘀𝗲. 💌 Learn more about HIV rapid test (https://lnkd.in/daKBsWcs) and join us in the fight against AIDS.  #WorldAIDSDay #HIV #PRIMALab #Health #RapidTest #Prevention #WAD2024

South Africa's battle against HIV/AIDS signals resilience and progress in the face of a devastating epidemic. From initial denial to pioneering global strategies, the nation has slashed #HIV prevalence and increased treatment outcomes. With unwavering political commitment and robust community engagement, #SouthAfrica integrates prevention, treatment, and support seamlessly into its healthcare fabric. By expanding access to life-saving #antiretroviral therapy and championing innovative research, the country sets a precedent for tackling HIV/AIDS with evidence-based strategies. International partnerships and local initiatives converge to combat stigma, promote testing, and empower affected communities. As South Africa charts a path towards an #AIDS free future, its journey offers invaluable lessons for other African nations. Through shared knowledge and collective action, these countries can employ South Africa's progress to build resilient #healthcare systems and ensure equitable access to HIV/AIDS prevention and treatment. Together, we can turn the tide on this epidemic and enable healthier, more empowered societies. This report falls under our 'Insightful Articles' column on our website. Read in full here: https://lnkd.in/d9_TC88n 👉🏽 Like, repost, comment, and help us create more awareness. ✍🏾: Written by Favour Olumuyiwa 🔍: Reviewed by Tomi Abe, Adetoro Adetayo 🖼️: Illustration by Tomi Abe #Susinsight #SusinsightArticle #AdvancingSustainability #HarnessingKnowledgeForImpact #AdvancingSustainabilityInAfrica

ViiV Healthcare CEO and GSK president of global health Deborah Waterhouse discusses how gender inequality limits women’s access to life-saving treatments for diseases like HIV, TB, and malaria. Read more: https://dvx.cm/weekx7 #sponsored by GSK and ViiV Healthcare #GlobalHealth #healthforall

#HumanImmunodeficiencyVirus (HIV) poses a significant global health challenge, leading to severe immune system damage and ultimately AIDS if untreated. Early detection is crucial for effective management and treatment. The HIV p24 Antigen Test Cassette (Whole Blood/Serum/Plasma) is designed for the in vitro detection of the p24 antigen associated with HIV type 1. This test provides rapid results, aiding in the differential diagnosis of HIV infections within minutes, making it an essential tool for healthcare providers. Its versatility allows it to be used with whole blood, serum or plasma, ensuring accessibility in various clinical settings. In summary, this test plays a vital role in early HIV detection and management, ultimately improving patient outcomes and public health efforts. 🔎https://lnkd.in/gAt7yG9F #HIV #HIVDetection #PublicHealth #AIDS #HealthCare #RapidTest #MedicalInnovation #GlobalHealth #InVitroDiagnosis #AllTest #Innovation

DTHF's Linda-Gail Bekker spoke to SABC about the challenges of current PrEP options. The interview also discusses the next important steps for Lenacapavir, a twice-yearly PrEP injectable, which is in the final stages of its clinical trials, and has already been shown to be superior in its effectiveness to oral daily PrEP in preventing HIV acquisition in cisgender women (in clinical trials held in Uganda and South Africa). "The most important thing we can do now in the [HIV] response, is to try to turn off new infections. As new infections are mostly happening amongst young people, who struggle to take a daily pill. Besides our usual prevention options, we do have daily oral PrEP and this requires daily activities and young people struggle to do that, so this gives us a new and very exciting option. " "Like any new intervention it needs real demand creation, and I am not sure we really have done that. If you compare what we did during covid, to get people to get vaccinated, we have done nothing on that scale, despite the fact that we are a country that has the biggest HIV problem, in the world, and every week, many young people in our country become newly infected. But when we do actually offer it to young people in our programmes, we see that there is acceptance and uptake, but quite soon that falls off and I think that’s just about doing something daily when you are young and you have lot going on in your life." "We have to see what the price of the drug is and then we will need to see will our government procure it. Will we be able to get it into the public sector, and will it be widely available. If so, we need to make sure that we are promoting it as much as we can and then the wonderful thing is that young people now really just need to make a decision twice every year, to go in and have the injection so it really unburdens the users and hopefully it unburdens the health system as well. And we really hope South Africa takes advantage of this." Watch the full interview here: https://lnkd.in/d-R2TVw8 #PURPOSE1 #Lenacapavir #longactingPrEP #PrEP #HIVprevention #demandcreation #injectablePrEP